Fatty Liver Disease, now increasingly referred to as MASLD, is one of the most common yet underdiagnosed metabolic conditions encountered in clinical practice today. Every young doctor must understand its strong association with obesity, diabetes, dyslipidemia, and cardiovascular risk, even in patients who appear asymptomatic. Early recognition through simple clinical clues, laboratory markers, and imaging can prevent progression to cirrhosis and hepatocellular carcinoma. With evolving nomenclature and guidelines, staying updated on screening, lifestyle interventions, and referral pathways is crucial for effective long-term patient care.
Consultant Internist & Hepatologist, Sultan Bin Abdulaziz Humanitarian City, Riyadh
Dr. Mahmoud Al Desoky is a highly experienced Consultant Internist and Gastroenterologist with over 25 years of clinical, academic, and teaching expertise across Saudi Arabia and Egypt. He is currently serving as a Consultant Internist and Gastroenterologist at Sultan Bin Abdulaziz Humanitarian City (SBAHC), Riyadh, a role he has held since October 2020, where he is actively involved in advanced patient care, health education, and medical training. In parallel, he has been an Assistant Professor of Medicine at the Faculty of Medicine, Minia University since 2014, contributing extensively to undergraduate and postgraduate medical education. Dr. Al Desoky has also held senior consultant roles at NMC Healthcare Al Salam, Riyadh, and Minia University Hospital, with longstanding experience as a Consultant Gastroenterologist since 2002. He began his medical career in 2000 and has consistently combined clinical excellence with academic leadership. He holds a Bachelor of Medicine and Surgery and a Master’s degree in Medicine from Minia University and has further strengthened his leadership and problem-solving capabilities through the McKinsey.org Forward Program. His career reflects a strong commitment to patient education, public health, and the training of future physicians.